In the original publication [], there was a mistake in Table 4 as published. The column titles presented in Table 4 were identical to the titles in Table 3. Furthermore, we would like to bring to attention that adjustments were made to the data presented in the last four rows of the table. This was necessitated due to an error that occurred during the writing process. We would like to highlight that the data in the first two rows coincided with the data in the last two rows. Subsequently, the correct data has been provided in order to align with the text and ensure accuracy and consistency. No patients were found in the age groups of 61–70 and >70 years. The corrected Table 4 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.
Table 4.
Changes in the mean number of sick-leave days per patient within 12 months after the prescription of Utipro® Plus versus within 12 months prior to the prescription of Utipro® Plus.
Reference
- Kostev, K.; Cai, T. Cystitis and Utipro® Plus: Real-World Evidence. Healthcare 2023, 11, 2564. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).